Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/06/20242:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BBarnes Group Inc
05/06/20242:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CSLCarlisle Companies Inc
05/06/20242:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EXPDExpeditors International of Washington Inc
05/06/20242:28PMPR Newswire (US)BUILD-A-BEAR CELEBRATES THE GOOD 'STUFF' WITH NEW CAMPAIGN TO ADD EVEN MORE HEART TO LIFENYSE:BBWBuild A Bear Workshop Inc
05/06/20242:27PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:GSCEGoldman Sachs Group Inc (PK)
05/06/20242:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BBarnes Group Inc
05/06/20242:27PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:UNRVDBlum Holdings Inc (QB)
05/06/20242:27PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:BACRPBank of America Corp (PK)
05/06/20242:27PMBusiness WireKBRA Assigns Preliminary Ratings to BBCMS 2024-C26
05/06/20242:26PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
05/06/20242:26PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:NEPTFNeptune Wellness Solutions Inc (PK)
05/06/20242:26PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:TNTTFToronto Dominion Bank (PK)
05/06/20242:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BBarnes Group Inc
05/06/20242:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYBTStock Yards Bancorp Inc
05/06/20242:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CSLCarlisle Companies Inc
05/06/20242:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BBarnes Group Inc
05/06/20242:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EXPDExpeditors International of Washington Inc
05/06/20242:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BBarnes Group Inc
05/06/20242:21PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
05/06/20242:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EXPDExpeditors International of Washington Inc
05/06/20242:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
05/06/20242:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELHCelsius Holdings Inc
05/06/20242:20PMBusiness WireCLARIANE : Exécution du plan de renforcement de la structure financière de Clariane - cession de l’activité Hospitalisation à Domicile (HAD) en FranceEU:CLARIClariane SE
05/06/20242:20PMBusiness WireCLARIANE: Implementation of the Plan to Strengthen Clariane's Financial Structure - Disposal of the Hospitalisation à Domicile (HAD) Activity in FranceEU:CLARIClariane SE
05/06/20242:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FFIVF5 Inc
05/06/20242:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
05/06/20242:19PMPR Newswire (US)Optimizely Named a Leader in B2B Commerce Solutions
05/06/20242:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ISRGIntuitive Surgical Inc
05/06/20242:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ROGRogers Corp
05/06/20242:18PMBusiness WireSeek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments